MétaCan
Menu
Back to cohort
Record W4381376533 · doi:10.2337/db23-1159-p

1159-P: Impaired Insulin Sensitivity Relates to Preclinical Biomarkers of Neurodegenerative Disease in Young Adults With and Without Type 1 Diabetes (T1D)

2023· article· en· W4381376533 on OpenAlexaboutno aff
Allison Shapiro, Christina Coughlan, CARISSA VINOVSKIS, Tim Vigers, MEGHAN E. PAULEY, Janet K. Snell‐Bergeon, Alexis MacDonald, Kalie L. Tommerdahl, Daniël H. van Raalte, IAN DE BOER, Robert G. Nelson, Laura Pyle, Kristen J. Nadeau, Petter Bjornstad

Bibliographic record

VenueDiabetes · 2023
Typearticle
Languageen
FieldNeuroscience
TopicNeurological Disorders and Treatments
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineInternal medicineDiabetes mellitusEndocrinologyDementiaBiomarkerPathophysiologyType 2 diabetesAmyloid (mycology)AgeingInsulinDiseasePathologyBiology

Abstract

fetched live from OpenAlex

In adults with diabetes, impaired insulin sensitivity (IS) has been implicated in the risk for neurodegenerative diseases, namely Alzheimer's Disease and its related dementias (AD/ADRD). However, the link between diabetes pathophysiology and AD/ADRD in youth-onset T1D is unknown. Thus, we examined the relationships between IS and preclinical biomarkers of AD/ADRD in 30 young adults with T1D (age 23±3 years, diabetes duration 13±5 years, 53% female, HbA1c 7.9±1.1%, BMI 25±3 kg/m2) and 20 age-similar healthy controls (age 25±3, 50% female, HbA1c 5.2±0.3%, BMI: 23±2). Whole-body (M-value mg/kg/min) and adipose (free fatty acid [%FFA] suppression) IS were measured by hyperinsulinemic-euglycemic clamps (80 mU/m2/min). Preclinical biomarkers of AD/ADRD including Neurofilament Light (NfL), Glial Fibrillary Acidic Protein (GFAP), Amyloid-β40 (Aβ40), Amyloid-β42 (Aβ42), and total Tau were measured in plasma via ultra-sensitive immunoassays (SIMOA Quanterix). Pearson correlations were run to examine the relationships among preclinical biomarkers, M-value and %FFA suppression across all participants. Young adults with T1D had higher NfL (2.14 [1.72, 2.56] vs. 1.40 [0.83, 1.97] pg/mL, p=0.046), Aβ40 (50.8 [47.6, 54.1] vs. 45.4 [41.2, 49.6] pg/mL, p=0.048) and Aβ42 (2.50 [2.36, 2.65] vs. 2.23 [2.04, 2.41] pg/mL, p=0.026) compared to healthy controls. No differences were observed in total Tau or GFAP between the two groups. Across all participants, M-value was inversely correlated with Aβ40 (r: -0.36, p=0.018), Aβ42 (r:-0.33, p=0.030) and NfL (r:-0.31, p=0.045). %FFA suppression inversely correlated with NfL (r: -0.70, p<0.0001). Preclinical biomarkers of AD/ADRD were altered in young adults with T1D, compared to healthy young adults, and in all young adults, were related to impaired whole body and adipose IS. Ongoing longitudinal studies will examine the clinical impact of these findings with brain imaging and cognitive testing. Disclosure A.Shapiro: None. I.De boer: Advisory Panel; AstraZeneca, Boehringer Ingelheim and Eli Lilly Alliance, Boehringer Ingelheim International GmbH, Otsuka America Pharmaceutical, Inc., Bayer Inc., Consultant; George Clinical, Gilead Sciences, Inc., Medscape, Research Support; Dexcom, Inc. R.G.Nelson: None. L.Pyle: None. K.J.Nadeau: None. P.Bjornstad: Advisory Panel; AstraZeneca, Novo Nordisk, Lilly, Horizon Therapeutics plc, Boehringer Ingelheim (Canada) Ltd., LG Chem, Consultant; Bayer Inc., Bristol-Myers Squibb Company. C.Coughlan: None. C.Vinovskis: None. T.B.Vigers: None. M.E.Pauley: None. J.K.Snell-bergeon: None. A.A.Macdonald: None. K.L.Tommerdahl: None. D.Van raalte: Consultant; Boehringer Ingelheim and Eli Lilly Alliance, AstraZeneca, Merck & Co., Inc., Research Support; Boehringer Ingelheim and Eli Lilly Alliance, AstraZeneca, Merck & Co., Inc.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.002
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.014
Threshold uncertainty score0.638

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.024
GPT teacher head0.270
Teacher spread0.246 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueDiabetesSame topicNeurological Disorders and TreatmentsFrench-language works237,207